Pasithea Therapeutics (KTTA) Shareholder's Equity (2020 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 595,226.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.08 Bn
10 Pasithea Therapeutics 17.41 Mn 17.41 Mn - 54.81 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 54.81 Mn
Dec 31, 2025 55.22 Mn
Sep 30, 2025 12.21 Mn
Jun 30, 2025 15.18 Mn
Mar 31, 2025 12.98 Mn
Dec 31, 2024 14.78 Mn
Sep 30, 2024 17.81 Mn
Jun 30, 2024 16.18 Mn
Mar 31, 2024 19.88 Mn
Dec 31, 2023 23.40 Mn
Sep 30, 2023 28.37 Mn
Jun 30, 2023 35.59 Mn
Mar 31, 2023 39.14 Mn
Dec 31, 2022 42.50 Mn
Sep 30, 2022 46.79 Mn
Jun 30, 2022 51.32 Mn
Mar 31, 2022 49.98 Mn
Dec 31, 2021 51.42 Mn
Sep 30, 2021 16.48 Mn
Jun 30, 2021 470,078.00
Mar 31, 2021 900,672.00
Dec 31, 2020 241,355.00